{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T13:24:41Z","timestamp":1768829081176,"version":"3.49.0"},"reference-count":14,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004600","name":"Kyungpook National University Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004600","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012403","name":"Texas Biomedical Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012403","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.jaip.2019.05.010","type":"journal-article","created":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T16:06:03Z","timestamp":1558541163000},"page":"2851-2853.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Carbonic anhydrase inhibitor\u2013induced Stevens-Johnson syndrome\/toxic epidermal necrolysis leads to extensive cutaneous involvement"],"prefix":"10.1016","volume":"7","author":[{"given":"Sujeong","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Yun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong Yoon","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hye-Jung","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eun-Jung","family":"Jo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae-Woo","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hye-Kyung","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung-Won","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young-Koo","family":"Jee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hye-Ryun","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong-Myung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2019.05.010_bib1","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1001\/archderm.1993.01680220104023","article-title":"Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme","volume":"129","author":"Bastuji-Garin","year":"1993","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaip.2019.05.010_bib2","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/tpj.2015.25","article-title":"HLA-B*59:01: a marker for Stevens-Johnson syndrome\/toxic epidermal necrolysis caused by methazolamide in Han Chinese","volume":"16","author":"Yang","year":"2016","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.jaip.2019.05.010_bib3","first-page":"5217","article-title":"HLA-B5901 serotype participates in toxic epidermal necrolysis induced by methazolamide: a case report of Chinese female","volume":"28","author":"Zhu","year":"2017","journal-title":"Biomed Res India"},{"key":"10.1016\/j.jaip.2019.05.010_bib4","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/ijd.13924","article-title":"Methazolamide-induced toxic epidermal necrolysis in a man carrying HLA-B*59:01: successful treatment with infliximab and glucocorticoid","volume":"57","author":"Jiang","year":"2018","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaip.2019.05.010_bib5","doi-asserted-by":"crossref","first-page":"867","DOI":"10.3904\/kjim.2018.126","article-title":"Genetic markers of severe cutaneous adverse reactions","volume":"33","author":"Jung","year":"2018","journal-title":"Korean J Intern Med"},{"key":"10.1016\/j.jaip.2019.05.010_bib6","doi-asserted-by":"crossref","first-page":"879","DOI":"10.2217\/pgs.10.54","article-title":"HLA-B*5901 is strongly associated with methazolamide-induced Stevens-Johnson syndrome\/toxic epidermal necrolysis","volume":"11","author":"Kim","year":"2010","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.jaip.2019.05.010_bib7","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1001\/archopht.1997.01100150552021","article-title":"Stevens-Johnson syndrome induced by methazolamide treatment","volume":"115","author":"Shirato","year":"1997","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jaip.2019.05.010_bib8","doi-asserted-by":"crossref","first-page":"D784","DOI":"10.1093\/nar\/gku1166","article-title":"Allele frequency net 2015 update: new features for HLA epitopes, KIR and disease and HLA adverse drug reaction associations","volume":"43","author":"Gonzalez-Galarza","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jaip.2019.05.010_bib9","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1399-0039.2005.00386.x","article-title":"Allelic and haplotypic diversity of HLA-A, -B, -C, -DRB1, and -DQB1 genes in the Korean population","volume":"65","author":"Lee","year":"2005","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.jaip.2019.05.010_bibE1","doi-asserted-by":"crossref","first-page":"879","DOI":"10.2217\/pgs.10.54","article-title":"HLA-B*5901 is strongly associated with methazolamide-induced Stevens-Johnson syndrome\/toxic epidermal necrolysis","volume":"11","author":"Kim","year":"2010","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.jaip.2019.05.010_bibE2","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/ijd.13924","article-title":"Methazolamide-induced toxic epidermal necrolysis in a man carrying HLA-B*59:01: successful treatment with infliximab and glucocorticoid","volume":"57","author":"Jiang","year":"2018","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaip.2019.05.010_bibE3","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/tpj.2015.25","article-title":"HLA-B*59:01: a marker for Stevens-Johnson syndrome\/toxic epidermal necrolysis caused by methazolamide in Han Chinese","volume":"16","author":"Yang","year":"2016","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.jaip.2019.05.010_bibE4","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1001\/archopht.1997.01100150552021","article-title":"Stevens-Johnson syndrome induced by methazolamide treatment","volume":"115","author":"Shirato","year":"1997","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jaip.2019.05.010_bibE5","first-page":"5217","article-title":"HLA-B5901 serotype participates in toxic epidermal necrolysis induced by methazolamide: a case report of Chinese female","volume":"28","author":"Zhu","year":"2017","journal-title":"Biomed Res India"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219819304659?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219819304659?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:21:49Z","timestamp":1761974509000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219819304659"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":14,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S2213219819304659"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2019.05.010","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Carbonic anhydrase inhibitor\u2013induced Stevens-Johnson syndrome\/toxic epidermal necrolysis leads to extensive cutaneous involvement","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2019.05.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}